Molina Healthcare Inc stock analysis: revenue down 3.5% (TTM), a 1.0% operating margin and a Sell signal from our scoring model. See the full data.
Health Care
-
-
Zoetis Inc. stock analysis: elite margins, a 13.1 P/E and stalled growth. See how the Quality, Growth and Opportunity scores add up to a Buy signal.
-
BiotechnologyUS Stocks
Legend Biotech Grows Revenue 51.9% but Trades Near Its Two-Year Low as Net Losses Linger
Legend Biotech stock analysis: revenue up 51.9% and a Growth score of 93, but a net loss and thin cash flow keep our scoring model at Hold.
-
Health Care ServicesUS Stocks
Tempus AI Has Grown Revenue 54.6% a Year, but Losses and 27.5 Times Book Value Put the Model at Sell
Tempus AI stock analysis: 54.6% five-year revenue growth, but losses and 27.5x book value leave our scoring model at Sell.
-
PharmaceuticalsUS Stocks
Hims & Hers Jumps 10% in a Day, but Losses, an FTC Lawsuit and Thin Cash Flow Keep the Model at Hold
Hims & Hers Health stock analysis: revenue up 38%, but losses, an FTC lawsuit and a faulty cash flow figure keep the model at Hold.
-
BiotechnologyUS Stocks
Recursion Burned Through $197 Million in Six Months – and the Model Still Rates It Sell After a Volatile October
Recursion Pharmaceuticals stock analysis: $197M of cash burned in six months and 28% more shares. Why the model rates RXRX a Sell before its November data.
-
BiotechnologyUS Stocks
BeOne Medicines Has Doubled Off Its Low on Brukinsa’s Growth – but at 64 Times Earnings, the Model Stops at Hold
BeOne Medicines stock analysis: Brukinsa drove 29.6% revenue growth and strong margins, but a 64.06 P/E keeps the model’s signal at Hold.